Molina Healthcare (NYSE:MOH) Given Equal Weight Rating at Stephens

Stephens reissued their equal weight rating on shares of Molina Healthcare (NYSE:MOH) in a research note issued to investors on Thursday morning, Benzinga reports. Stephens currently has a $320.00 target price on the stock.

Other equities research analysts also recently issued reports about the company. Baird R W raised Molina Healthcare to a strong-buy rating in a research report on Thursday, May 30th. Truist Financial cut their target price on Molina Healthcare from $440.00 to $400.00 and set a buy rating for the company in a research note on Monday, July 15th. Robert W. Baird began coverage on shares of Molina Healthcare in a research note on Thursday, May 30th. They set an outperform rating and a $405.00 price target on the stock. Bank of America cut shares of Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 price objective for the company. in a research note on Thursday, March 28th. Finally, TD Cowen reduced their price objective on shares of Molina Healthcare from $412.00 to $351.00 and set a buy rating for the company in a report on Wednesday. One research analyst has rated the stock with a sell rating, five have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and an average target price of $376.18.

Molina Healthcare Stock Up 12.3 %

MOH opened at $324.25 on Thursday. The business has a 50 day moving average of $307.61 and a 200-day moving average of $353.85. The stock has a market capitalization of $19.00 billion, a price-to-earnings ratio of 17.59, a P/E/G ratio of 0.89 and a beta of 0.58. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. Molina Healthcare has a 1-year low of $282.96 and a 1-year high of $423.92.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, beating the consensus estimate of $5.73 by $0.13. The firm had revenue of $9.88 billion during the quarter, compared to analysts’ expectations of $9.75 billion. Molina Healthcare had a net margin of 2.84% and a return on equity of 29.17%. The business’s quarterly revenue was up 18.7% compared to the same quarter last year. During the same period in the prior year, the company earned $5.65 EPS. As a group, sell-side analysts anticipate that Molina Healthcare will post 23.56 earnings per share for the current year.

Insider Buying and Selling at Molina Healthcare

In other news, COO James Woys sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the transaction, the chief operating officer now directly owns 53,613 shares in the company, valued at $18,504,526.95. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Molina Healthcare news, Director Ronna Romney sold 250 shares of the business’s stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total transaction of $85,817.50. Following the completion of the sale, the director now directly owns 16,945 shares of the company’s stock, valued at approximately $5,816,710.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO James Woys sold 10,000 shares of the company’s stock in a transaction dated Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the transaction, the chief operating officer now owns 53,613 shares in the company, valued at $18,504,526.95. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. grew its position in Molina Healthcare by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 6,585,954 shares of the company’s stock valued at $2,379,571,000 after purchasing an additional 23,715 shares in the last quarter. Capital World Investors grew its holdings in shares of Molina Healthcare by 0.3% in the 4th quarter. Capital World Investors now owns 5,490,147 shares of the company’s stock valued at $1,983,645,000 after acquiring an additional 14,775 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Molina Healthcare by 12.8% in the fourth quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock valued at $1,384,215,000 after acquiring an additional 436,060 shares during the last quarter. Capital Research Global Investors increased its position in shares of Molina Healthcare by 5.4% in the fourth quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock valued at $878,086,000 after acquiring an additional 123,894 shares during the last quarter. Finally, Capital International Investors raised its holdings in Molina Healthcare by 0.9% during the first quarter. Capital International Investors now owns 1,665,801 shares of the company’s stock worth $684,361,000 after acquiring an additional 15,264 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.